Germany’s Merck will acquire Minneapolis‑based Bio‑Techne for $73 a share, a deal worth about $11.3 billion that expands Merck’s life‑science footprint.

A University of Minnesota rodent study found unilateral DBS sped decision‑making as effectively as bilateral stimulation, strengthening the case for simpler adaptive implants.

Abbott Northwestern has added histotripsy — a noninvasive, sound‑wave therapy that can mechanically destroy some liver tumors — expanding local treatment options. Early studies are promising but longer follow‑up is needed.

NOAA's SOLAR‑1 is now operational and will deliver CME imagery to forecasters in about 30 minutes, sharpening aurora forecasts and giving operators more time to protect infrastructure.

A St. Paul firm adapted Air Tractor planes with Heatwave floats that scoop 800 gallons in seconds, promising faster, safer wildfire response across Minnesota.

At its new Minnetonka ARCH campus, Stratasys hosted lawmakers and investors as it touted federal partnerships, a $120M investment and a 2026 revenue outlook tied to defense work.

FBI records and a National Archives clip show Anoka officers observed an unexplained multicolored object on Feb. 19, 2025. The sighting remains unresolved.

Mayo Clinic and Bayesian Health unveiled an AI tool to flag hospitalized patients who may need palliative care; an internal trial showed referral rates jumped 44%.

The Minnesota Senate voted unanimously to ban AI "nudification" tools that make nonconsensual nude images, creating civil remedies and steep penalties for operators. The bill now heads to the governor.

SkyWater's Fab 25 purchase and a pending IonQ acquisition have lifted revenue and capacity, positioning Bloomington as a hub in the U.S. chip re‑shoring push. The deals mean more factory space, higher payrolls and a bigger role in quantum hardware supply chains.

Endogenex raised $50M to push its ReCET endoscopic therapy into a larger clinical trial. The Plymouth company is racing toward readouts expected in late 2026.

Hormel Institute scientists helped map human antibodies that bind poliovirus capsids, producing structural blueprints that could guide antiviral biologics.

Pivot Bio has moved its global headquarters to Minnetonka’s Carlson Towers, bringing a roughly $2 billion ag‑tech company closer to Midwestern corn growers.